Infant Maternal Vaccine by Pfizer Receives FDA Approval
The Food and Drug Administration (FDA) has granted approval for a new vaccine developed by Pfizer to protect infants from respiratory syncytial virus (RSV), which is the leading cause of hospitalization among babies in the U.S. Pfizer’s RSV shot is already available for older adults. This vaccine is the second treatment approved by the FDA …